Seasonal malaria chemoprevention (SMC) is a highly effective intervention to prevent malaria in those most vulnerable to the disease's effects. It involves administering monthly doses of antimalarial drugs to children aged 3-59 months during peak malaria transmission season.
Our SMC programme in Burkina Faso, Chad and Nigeria is top rated by GiveWell for its effectiveness.In 2020 we expanded our SMC work to Togo and currently undertaking research studies to establish if SMC can have similar results in Mozambique and Uganda.
We strive to continuously improve quality of SMC implementation and to contribute to the evidence base through monitoring and evaluation (M&E) and research. Find out about our work on SMC implementation in our SMC newsletter.